News Desk Verified @newsdesk 3 June 2025
MHRA Approves Aumolertinib to Treat Non-Small Cell Lung Cancer

As with all products, we will keep its safety under close review The Medicines and Healthcare products Regulatory Agency (MHRA) has...
MHRA Approves Aumolertinib to Treat Non-Small Cell Lung Cancer

What do you think?

Log in to reply to this SHMOOZ post.

There are no replies yet.